(Q35068013)

English

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

author name string

Kun Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Tiantian Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nan Ge

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Li Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Xiaotian Yuan

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jikai Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Feng Kong

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Chang Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Hongbo Ren

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Keqiang Yan

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sanyuan Hu

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Zhonghua Xu

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Magnus Björkholm

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yidong Fan

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Shengtian Zhao

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Cheng Liu

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dawei Xu

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

12428-12439

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Telomerase as a "stemness" enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutations in cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

European guidelines on upper tract urothelial carcinomas: 2013 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Highly recurrent TERT promoter mutations in human melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutations in familial and sporadic melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Telomerase directly regulates NF-κB-dependent transcription.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Regulation of the human catalytic subunit of telomerase (hTERT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Role of telomeres and telomerase in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Prognostic factors for upper urinary tract urothelial carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Actions of human telomerase beyond telomeres

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

8 July 2018

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-κB-dependent transcription

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4322995

27 September 2018

Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/25474136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/25474136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TERT regulates cell survival independent of telomerase enzymatic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25474136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25474136

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.2660

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35068013&oldid=1442690583"